Real-world data show maternal RSVpreF vaccination was 82% effective against infant RSV LRTI hospitalization through 3 months.
|Articles|September 4, 2014
Diclectin effective for nausea and vomiting of pregnancy (VIDEO)
Pregnant women experiencing morning sickness may gain relief from Diclectin, a combination of doxylamine succinate and pyridoxine hydrochloride.
Advertisement
Pregnant women experiencing morning sickness may gain relief from Diclectin, a combination of doxylamine succinate and pyridoxine hydrochloride.
Thsi video, provided by The Doctor's Channel, is part of the
Advertisement
Related to this article
Peter Hsin, BS, discusses a meta-analysis linking perioperative ketamine to lower early postpartum depressive symptoms after cesarean delivery.
The FDA granted accelerated approval to Voceryq to reduce papilloma excision surgeries in adults with recurrent respiratory papillomatosis.
Neither maternal MOUD dose nor umbilical cord opioid levels were associated with neonatal opioid withdrawal syndrome severity.
ACOG advises against GLP-1 receptor agonists in pregnancy and recommends considering discontinuation 1 to 2 months before conception.
Soma Mandal, MD, MSCP, says removing MHT boxed warnings is overdue but calls for transparency on the FDA's product-specific rationale.
CMS' proposed G-codes, which experts stated would cause confusion in combination with the AMA's proposed codes, were not included in the final fee schedule for 2027, according to ACOG.
Matthew Nudy, MD, on estrogen's cardiovascular effects, risk assessment, and hormone therapy safety in younger menopausal women.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Centers for Medicare, Medicaid Services includes AMA's obstetric codes in 2027 fee schedule
2
Reactions to FDA's boxed warning removals for menopausal hormone therapy
3
Top headlines in women's health from October 2026
4
Top video interviews from The Menopause Society 2026 Annual Meeting
5